How Barrett was paid
$8.4M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Paul A. LaVioletteChief Executive Officer and Co-Chairman | — | — | — | — | — |
| Kevin P. DanahyChief Commercial Officer | $512,500 | $102,473 | — | $1,437 | $616,410 |
| Darrin R. UeckerChief Technology Officer and Director | $512,500 | $102,473 | — | $1,437 | $616,410 |
| Burke T. BarrettFormer Chief Executive Officer and Director | $327,318 | $108,510 | $7,998,340 | $1,437 | $8,435,605 |
What changed and why
- $8.4M$8.4M Barrett’s 2024 total included a $8.0M option award and $21,875 severance payment.
- $616K$616,410 Danahy and Uecker each received total 2024 compensation, including $102,473 bonuses.
- 2024 Barrett served as CEO from May through December after succeeding Danahy.
- 70%2025 LaViolette joined as CEO with a $725,000 base salary and 70% target annual bonus.
- No 2024 financial performance measures linked compensation actually paid to PEOs or non-PEO NEOs.
- $1.3M2024 Compensation Actually Paid was $1,305,872 for the PEO and negative $12,625,697 for non-PEO NEOs.
Other Pulse Biosciences proxy statements
- 2026 proxy statement
Paul A. LaViolette paid $7.4M.
Filed May 11, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.